RBOT vs. LFWD, MLSS, NTRB, COCH, CLGN, IMRX, ADEX, ABIO, BHG, and LUCD
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include ReWalk Robotics (LFWD), Milestone Scientific (MLSS), Nutriband (NTRB), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), Immuneering (IMRX), Adit EdTech Acquisition (ADEX), ARCA biopharma (ABIO), Bright Health Group (BHG), and Lucid Diagnostics (LUCD). These companies are all part of the "medical" sector.
Vicarious Surgical (NYSE:RBOT) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.
ReWalk Robotics has higher revenue and earnings than Vicarious Surgical. ReWalk Robotics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
Vicarious Surgical has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500.
Vicarious Surgical currently has a consensus target price of $0.67, indicating a potential upside of 57.87%. ReWalk Robotics has a consensus target price of $13.00, indicating a potential upside of 156.92%. Given ReWalk Robotics' stronger consensus rating and higher probable upside, analysts plainly believe ReWalk Robotics is more favorable than Vicarious Surgical.
47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are owned by institutional investors. 11.7% of Vicarious Surgical shares are owned by insiders. Comparatively, 2.1% of ReWalk Robotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Vicarious Surgical received 5 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 38.10% of users gave Vicarious Surgical an outperform vote.
Vicarious Surgical has a net margin of 0.00% compared to ReWalk Robotics' net margin of -134.52%. ReWalk Robotics' return on equity of -33.41% beat Vicarious Surgical's return on equity.
In the previous week, ReWalk Robotics had 12 more articles in the media than Vicarious Surgical. MarketBeat recorded 12 mentions for ReWalk Robotics and 0 mentions for Vicarious Surgical. ReWalk Robotics' average media sentiment score of 0.04 beat Vicarious Surgical's score of 0.00 indicating that ReWalk Robotics is being referred to more favorably in the news media.
Summary
ReWalk Robotics beats Vicarious Surgical on 11 of the 17 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
